Article

Longitudinal examination of perfusion and angiogenesis markers in primary colorectal…

medRxiv · 2022 · Ariel I. Mundo

Key facts

Title Longitudinal examination of perfusion and angiogenesis markers in primary colorectal tumors shows distinct signatures for metronomic and maximum-tolerated dose strategies
First author Ariel I. Mundo
Journal medRxiv
Published Feb 10, 2022
DOI 10.1101/2022.02.07.479423
Product codes mentioned CCW, EOB, EOQ, ERA, FET, GCJ, GWG, HET, HIH, HRX, OCZ

At a glance

  • None FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature